Surface-modified liposomes with polyvinyl alcohol derivatives improve mucus penetration and oral absorption: A potential alternative to polyethylene glycol
European Journal of Pharmaceutics and Biopharmaceutics · 2027-01 · 230 · 115270
DOI: 10.1016/j.ejpb.2026.115270 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2027-01. Verfasst von Eriko Yamazoe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Mitsubishi Chemical Corporation.
Abstract (Originalsprache)
Polyethylene glycol-modified (PEG-modified) nanocarriers are widely used as mucus-penetrating systems for oral administration. In this study, we developed a low-molecular-weight polyvinyl alcohol (PVA) bearing alkyl groups at molecular ends as a potential alternative to PEG for imparting mucus permeability to nanocarriers. We also evaluated its effects on mucus permeability and its applicability to oral drug delivery. The particle sizes of PVA-modified liposomes (PVA-Lip) and PEG-modified liposomes (PEG-Lip) were approximately 150 nm and 130 nm, respectively, and both exhibited monodisperse size distributions. PVA-Lip showed greater apparent mucus permeability than PEG-Lip. Furthermore, when liposomes encapsulating fluorescein isothiocyanate-dextran with an average molecular weight of 3,000-5,000 (FD4) as a peptide model were orally administered to rats, PVA-Lip and PEG-Lip exhibited similar overall FD4 absorption, with insignificant differences in the area under the plasma concentration-time curve (AUC). In repeated oral administration studies, the AUC of PEG-Lip decreased by approximately 43 % compared with the initial dose, whereas that of PVA-Lip decreased minimally. This decreased AUC may be associated with antibody responses, and PVA-Lip may be less susceptible to antibody-related effects than PEG-Lip. Collectively, these findings suggest that alkyl-terminated PVA could be an alternative to PEG for oral delivery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan.
- Gohsenol R&D Group, Acetyl Polymers Technology Center, R&D Division, Advanced Films and Polymers Business Group, Mitsubishi Chemical Corporation, 13-1, Muroyama 2-chome, Ibaraki-shi, Osaka 567-0052, Japan.
- Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan. Electronic address: tahara@gifu-pu.ac.jp.
Förderung
- Mitsubishi Chemical Corporation
Zitieren
APA
Yamazoe, E., Morioka, T., Ito, T., & Tahara, K. (2027). Surface-modified liposomes with polyvinyl alcohol derivatives improve mucus penetration and oral absorption: A potential alternative to polyethylene glycol. European Journal of Pharmaceutics and Biopharmaceutics, 230, 115270. https://doi.org/10.1016/j.ejpb.2026.115270
Vancouver
Yamazoe E, Morioka T, Ito T, Tahara K. Surface-modified liposomes with polyvinyl alcohol derivatives improve mucus penetration and oral absorption: A potential alternative to polyethylene glycol. European Journal of Pharmaceutics and Biopharmaceutics. 2027;230:115270. doi:10.1016/j.ejpb.2026.115270
BibTeX
@article{Yamazoe2027,
author = {Yamazoe, Eriko and Morioka, Toshifumi and Ito, Takaaki and Tahara, Kohei},
title = {Surface-modified liposomes with polyvinyl alcohol derivatives improve mucus penetration and oral absorption: A potential alternative to polyethylene glycol},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2027},
volume = {230},
pages = {115270},
doi = {10.1016/j.ejpb.2026.115270}
}
EUVIMED